Christos Kosmas

6.8k total citations · 1 hit paper
207 papers, 5.1k citations indexed

About

Christos Kosmas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Christos Kosmas has authored 207 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Oncology, 59 papers in Pulmonary and Respiratory Medicine and 48 papers in Surgery. Recurrent topics in Christos Kosmas's work include Cancer Treatment and Pharmacology (40 papers), Colorectal Cancer Treatments and Studies (32 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). Christos Kosmas is often cited by papers focused on Cancer Treatment and Pharmacology (40 papers), Colorectal Cancer Treatments and Studies (32 papers) and Monoclonal and Polyclonal Antibodies Research (23 papers). Christos Kosmas collaborates with scholars based in Greece, United States and United Kingdom. Christos Kosmas's co-authors include Νicolas Tsavaris, St Gerontidis, Maria Vadiaka, Gérard Govers, Nick B. Tsavaris, N.G. Danalatos, Gregory W. McCarty, Johan Six, J. W. Harden and Timothy A. Quine and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Christos Kosmas

198 papers receiving 4.9k citations

Hit Papers

The Impact of Agricultural Soil Erosion on the Global Car... 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christos Kosmas Greece 34 1.6k 1.2k 819 702 572 207 5.1k
Ming Zhu China 39 879 0.5× 497 0.4× 422 0.5× 538 0.8× 238 0.4× 191 5.9k
Harvey Greenberg United States 33 925 0.6× 281 0.2× 587 0.7× 385 0.5× 463 0.8× 80 3.9k
Douglas Thompson United States 32 562 0.3× 748 0.6× 326 0.4× 1.1k 1.6× 327 0.6× 99 3.6k
Jacques Brisson Canada 63 3.5k 2.1× 171 0.1× 1.9k 2.3× 1.6k 2.2× 760 1.3× 243 12.2k
Alfredo Polo Spain 38 342 0.2× 2.2k 1.7× 673 0.8× 437 0.6× 354 0.6× 139 5.5k
Takayoshi Koike Japan 59 332 0.2× 972 0.8× 655 0.8× 842 1.2× 940 1.6× 462 18.1k
Robert A. Sanford United States 59 276 0.2× 690 0.6× 1.4k 1.8× 2.8k 4.0× 597 1.0× 207 12.6k
Michael J. Hall United States 38 3.0k 1.8× 187 0.2× 1.0k 1.3× 173 0.2× 691 1.2× 206 7.2k
David T. Price Canada 48 280 0.2× 290 0.2× 965 1.2× 1.4k 2.0× 349 0.6× 146 7.7k
Göran Wallin Sweden 48 939 0.6× 226 0.2× 374 0.5× 305 0.4× 1.6k 2.9× 219 8.5k

Countries citing papers authored by Christos Kosmas

Since Specialization
Citations

This map shows the geographic impact of Christos Kosmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos Kosmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos Kosmas more than expected).

Fields of papers citing papers by Christos Kosmas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos Kosmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos Kosmas. The network helps show where Christos Kosmas may publish in the future.

Co-authorship network of co-authors of Christos Kosmas

This figure shows the co-authorship network connecting the top 25 collaborators of Christos Kosmas. A scholar is included among the top collaborators of Christos Kosmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christos Kosmas. Christos Kosmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Durieux, Jared, et al.. (2024). Adhesive capsulitis: Utility of magnetic resonance imaging as a primary diagnostic tool and clinical management support. Current Problems in Diagnostic Radiology. 53(4). 464–469. 2 indexed citations
3.
Zografos, Eleni, Konstantinos Koutsoukos, Flora Zagouri, et al.. (2024). Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins. International Urology and Nephrology. 56(6). 1887–1898. 2 indexed citations
4.
Schulte, Klaus‐Martin, Jackie Gilbert, Christos Kosmas, et al.. (2023). Diagnosis and management of parathyroid carcinoma: a state-of-the-art review. Endocrine Related Cancer. 30(4). 24 indexed citations
5.
Kosmas, Christos, et al.. (2020). Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour. SHILAP Revista de lepidopterología. 1(1-2). 100047–100047. 2 indexed citations
6.
Kosmas, Christos, et al.. (2016). Computed tomography–guided percutaneous biopsy for vertebral neoplasms: a department's experience and hybrid biopsy technique to improve yield. Neurosurgical FOCUS. 41(2). E17–E17. 14 indexed citations
7.
Xynos, Ioannis, et al.. (2013). Chemotherapy ± Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer. Oncology. 84(5). 273–283. 11 indexed citations
8.
Tsakonas, Georgios & Christos Kosmas. (2008). Integration of novel targeted therapies into the systemic treatment of breast cancer--a review.. PubMed. 12(3). 319–27. 5 indexed citations
9.
Kosmas, Christos, Νicolas Tsavaris, Nikolaos Malamos, et al.. (2007). Docetaxel–ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines. Investigational New Drugs. 25(5). 463–470.
10.
Tsavaris, Νicolas, et al.. (2006). Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment. Leukemia & lymphoma. 47(3). 557–560. 3 indexed citations
11.
Kosmas, Christos, et al.. (2005). Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature. Journal of Neuro-Oncology. 71(1). 67–72. 30 indexed citations
12.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2003). Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Annals of Oncology. 14(4). 537–542. 26 indexed citations
14.
Kosmas, Christos, et al.. (2002). Raltitrexed (Tomudex) Administration in Patients Failing Multiple Prior Chemotherapy Regimens in Advanced Colorectal Cancer: a Pilot Study. Investigational New Drugs. 20(1). 133–136. 2 indexed citations
15.
Tsavaris, Νicolas, Aris Polyzos, Christos Kosmas, et al.. (2002). Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination. Chemotherapy. 48(2). 94–99. 15 indexed citations
16.
Kosmas, Christos, Νicolas Tsavaris, Maria Vadiaka, et al.. (2001). Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens. European Journal of Cancer. 37(8). 972–978. 32 indexed citations
17.
Tsavaris, N., Michalis Tzivras, Christos Kosmas, et al.. (1998). Combined Epirubicin, 5-Fluorouracil and Folinic Acid vs No Treatment for Patients with Advanced Pancreatic Cancer: A Prospective Comparative Study. Journal of Chemotherapy. 10(4). 331–337. 8 indexed citations
18.
Kosmas, Christos, D Snook, Nigel Courtenay-Luck, et al.. (1992). Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.. PubMed. 52(4). 904–11. 74 indexed citations
19.
Kosmas, Christos, et al.. (1989). Monoclonal antibodies for imaging and therapy. British Journal of Cancer. 59(2). 152–155. 30 indexed citations
20.
Yassoglou, N., et al.. (1987). Heavy metal contamination of roadside soils in the Greater Athens area. Environmental Pollution. 47(4). 293–304. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026